|
2018 Journal Article A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary carePatel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Bernard, Anne, Brown, Nigel Neil, Lampe, Guy, Buck, Lyndall, Saad, Nivene, Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Rosenberg, William and Powell, Elizabeth Ellen (2018). A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatology Communications, 2 (8), 893-905. doi: 10.1002/hep4.1208 |
|
2018 Journal Article Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genesRamnath, Divya, Irvine, Katharine M., Lukowski, Samuel W., Horsfall, Leigh U., Loh, Zhixuan, Clouston, Andrew D., Patel, Preya J., Fagan, Kevin J., Iyer, Abishek, Lampe, Guy, Stow, Jennifer L., Schroder, Kate, Fairlie, David P., Powell, Joseph E., Powell, Elizabeth E. and Sweet, Matthew J. (2018). Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight, 3 (14) e120274. doi: 10.1172/jci.insight.120274 |
|
2018 Journal Article Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosisPatel, Preya J., Banh, Xuan, Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew, Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C., Williams, Suzanne and Powell, Elizabeth E (2018). Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Internal Medicine Journal, 48 (2), 144-151. doi: 10.1111/imj.13667 |
|
2018 Journal Article Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitisMaradana, Muralidhara Rao, Yekollu, Suman Kumar, Zeng, Bijun, Ellis, Jonathan, Clouston, Andrew, Miller, Gregory, Talekar, Meghna, Bhuyan, Zaied Ahmed, Mahadevaiah, Sachin, Powell, Elizabeth E., Irvine, Katharine M., Thomas, Ranjeny and O'Sullivan, Brendan John (2018). Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. Metabolism: Clinical and Experimental, 78, 80-94. doi: 10.1016/j.metabol.2017.09.002 |
|
2017 Journal Article Alcohol consumption in diabetic patients with nonalcoholic fatty liver diseasePatel, Preya J., Smith, David, Connor, Jason P., Horsfall, Leigh U., Hayward, Kelly L., Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Stuart, Katherine A., Brown, Nigel N., Saad, Nivene, Clouston, Andrew D., Irvine, Katharine M., Russell, Anthony W., Valery, Patricia C. and Powell, Elizabeth E. (2017). Alcohol consumption in diabetic patients with nonalcoholic fatty liver disease. Canadian Journal of Gastroenterology and Hepatology, 2017 (1) 7927685, 7927685-8. doi: 10.1155/2017/7927685 |
|
2017 Journal Article Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosisHayward, Kelly L., Valery, Patricia C., Martin, Jennifer H., Karmakar, Antara, Patel, Preya J., Horsfall, Leigh U., Tallis, Caroline J., Stuart, Katherine A., Wright, Penny L., Smith, David D., Irvine, Katharine M., Powell, Elizabeth E. and Cottrell, W. Neil (2017). Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World Journal of Gastroenterology, 23 (40), 7321-7331. doi: 10.3748/wjg.v23.i40.7321 |
|
2017 Journal Article Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-managementHayward, Kelly L., Horsfall, Leigh U., Ruffin, Brittany J., Cottrell, W. Neil, Chachay, Veronique S., Irvine, Katharine M., Martin, Jennifer H., Powell, Elizabeth E. and Valery, Patricia C. (2017). Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management. Internal Medicine Journal, 47 (8), 952-955. doi: 10.1111/imj.13505 |
|
2017 Journal Article Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and managementPatel, Preya Janubhai, Hayward, Kelly Lee, Rudra, Rathiga, Horsfall, Leigh Ula, Hossain, Fabrina, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Clouston, Andrew Donald, Stuart, Katherine Anne, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Russell, Anthony William and Powell, Elizabeth Ellen (2017). Multimorbidity and polypharmacy in diabetic patients with NAFLD: implications for disease severity and management. Medicine, 96 (26) e6761, e6761. doi: 10.1097/MD.0000000000006761 |
|
2017 Journal Article Identifying areas of need relative to liver disease: geographic clustering within a health service districtEl-Atem, Nathan, Irvine, Katharine M., Valery, Patricia C., Wojcik, Kyle, Horsfall, Leigh, Johnson, Tracey, Janda, Monika, McPhail, Steven M. and Powell, Elizabeth E. (2017). Identifying areas of need relative to liver disease: geographic clustering within a health service district. Australian Health Review, 41 (4), 407-418. doi: 10.1071/AH15225 |
|
2025 Journal Article Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)Allen, Michelle J., Tulleners, Ruth, Brain, David, O’Beirne, James, Powell, Elizabeth E., Barnett, Adrian, Valery, Patricia C., Kularatna, Sanjeewa and Hickman, Ingrid J. (2025). Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial). BMC Health Services Research, 25 (1) 421, 1-13. doi: 10.1186/s12913-025-12580-5 |
|
2025 Journal Article A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia: designing the choice sets for the final surveySenanayake, Sameera, Barnett, Adrian, Brain, David, Allen, Michelle, Powell, Elizabeth E, O’Beirne, James, Valery, Patricia, Hickman, Ingrid J and Kularatna, Sanjeewa (2025). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia: designing the choice sets for the final survey. F1000Research, 14, 96. doi: 10.12688/f1000research.157017.1 |
|
2025 Journal Article High FIB4 is associated with increased risk of cirrhosis decompensation and liver-related mortality in at-risk patients with MASLDPowell, Elizabeth E., Hartel, Gunter, Irvine, Katharine M., O’Beirne, James, Bhasker, Vikas and Valery, Patricia C. (2025). High FIB4 is associated with increased risk of cirrhosis decompensation and liver-related mortality in at-risk patients with MASLD. Gastro Hep Advances, 4 (4) 100607, 1-3. doi: 10.1016/j.gastha.2024.100607 |
|
2024 Journal Article Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLDTulleners, Ruth, Barnett, Adrian, O'Beirne, James, Powell, Elizabeth, Hickman, Ingrid J., Valery, Patricia C., Kularatna, Sanjeewa, Stuart, Katherine, McIvor, Carolyn, Witness, Elen, Aikebuse, Melanie and Brain, David (2024). Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD. BMJ Open Gastroenterology, 11 (1) e001418. doi: 10.1136/bmjgast-2024-001418 |
|
2024 Journal Article A new treatment and updated clinical practice guidelines for MASLDPowell, Elizabeth E. (2024). A new treatment and updated clinical practice guidelines for MASLD. Nature Reviews Gastroenterology and Hepatology, 22 (2), 88-89. doi: 10.1038/s41575-024-01014-y |
|
2024 Journal Article Factors to consider in the selection of non-invasive fibrosis tests for metabolic dysfunction-associated steatotic liver diseaseGracen, Lucy, Hartel, Gunter, Irvine, Katharine M., Aikebuse, Melanie, Valery, Patricia C. and Powell, Elizabeth E. (2024). Factors to consider in the selection of non-invasive fibrosis tests for metabolic dysfunction-associated steatotic liver disease. Clinical Gastroenterology and Hepatology, 23 (5), 874-876.e3. doi: 10.1016/j.cgh.2024.09.014 |
|
2024 Conference Publication A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerationsAikebuse, Melanie, Gracen, Lucy, Sarraf, Babak, Mcphail, Steven, Russell, Anthony, O'Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerations. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Journal Article An Australian community-based metabolic dysfunction-associated steatotic liver disease care pathway for people with type 2 diabetes: barriers and considerationsGracen, Lucy, Aikebuse, Melanie, Sarraf, Babak, McPhail, Steven, Russell, Anthony, O’Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). An Australian community-based metabolic dysfunction-associated steatotic liver disease care pathway for people with type 2 diabetes: barriers and considerations. Patient Preference and Adherence, Volume 18, 1845-1855. doi: 10.2147/ppa.s468705 |
|
2024 Journal Article Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancerPowell, Elizabeth E., Roche, Shruti, Sarraf, Babak, Hartel, Gunter, Skoien, Richard, Leggett, Barbara, O'Beirne, James and Valery, Patricia C. (2024). Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer. JGH Open, 8 (7) e70000, e70000. doi: 10.1002/jgh3.70000 |
|
2024 Journal Article Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage studySarraf, B., Skoien, R., Hartel, G., O'Beirne, J., Clark, P. J., Collins, L., Leggett, B., Powell, E. E. and Valery, P. C. (2024). Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study. Public Health, 232, 178-187. doi: 10.1016/j.puhe.2024.04.030 |
|
2024 Conference Publication qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopyKleiner, David E., Clouston, Andrew D., Goodman, Zachary, Guy, Cynthia D., Brunt, Elizabeth M., Lackner, Carolin, Tiniakos, Dina G., Wee, Aileen, Yeh, Matthew, Leow, Wei Qiang, Chng, Elaine, Ren, Yayun, Goh, George Boon Bee, Powell, Elizabeth E., Rinella, Mary E., Sanyal, Arun J, Neuschwander-Tetri, Brent A., Younossi, Zobair, Charlton, Michael, Ratziu, Vlad, Harrison, Stephen A., Tai, Dean and Anstee, Quentin M. (2024). qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy. EASL Congress 2024, Milan, Italy, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(24)01444-2 |
